Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use

Official title: Study on the Management of COMISA

Run by University Hospital, Grenoble · NCT07743931 · Data updated 2026-11-12

This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Grenoble
Academic / other
Locations5 sites (Grenoble and 4 other locations)
StatusRecruiting
StartedSeptember 30, 2026
Main results expectedSeptember 2028
Study endsSeptember 2029
Registry record updatedOctober 5, 2026
Trial IDNCT07743931 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with COMISA (AHI ≥ 15 and ISI ≥ 15), CPAP‑naïve, and with no prior daridorexant treatment, affiliated with a national health insurance system.

Probably not a fit

Patients who cannot tolerate CPAP or daridorexant, or who have contraindications to daridorexant, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

COMISA is the co-occurrence of obstructive sleep apnea and insomnia. This minimal-risk interventional study will look at how a sleep‑wake medication (daridorexant 50 mg) given alongside CPAP affects adherence to CPAP and overall treatment outcomes in adults with COMISA. Participants must have AHI ≥ 15 and ISI ≥ 15, be CPAP‑naïve, and have no prior daridorexant treatment. The intervention combines standard CPAP therapy with daridorexant as part of routine care, with study procedures designed to reflect real-world practice. Outcomes will inform whether this combined approach improves sleep symptoms and device use in this patient group.

Why it matters

Potential benefit: If successful, patients could experience better sleep and higher CPAP adherence, potentially improving daytime functioning and quality of life.

How similar studies have gone: There is limited prior evidence on combining insomnia medications with CPAP for COMISA; this approach is innovative with some supportive data for each component separately.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient diagnosed with COMISA, defined by an apnea-hypopnea index (AHI) ≥ 15 events/hour and an Insomnia Severity Index (ISI) score ≥ 15, newly diagnosed and naïve to CPAP therapy and daridorexant treatment (no treatment for \> 5 years).
* Prescription of continuous positive airway pressure (CPAP) therapy combined with a prescription of daridorexant.
* Patient has provided informed consent to participate in the study.
* Patient is affiliated with a national health insurance system.

Exclusion Criteria:

* Severe hepatic impairment (contraindication to daridorexant treatment).
* Refusal of CPAP therapy and/or refusal of daridorexant treatment.
* Individuals covered under Articles L1121-5 to L1121-8 of the French Public Health Code.
* Staff members who have a hierarchical relationship with the principal investigator.
* Any patient who, in the opinion of the investigator, would be unable to comply with study procedures or the study schedule.

Where it's running

  • CHU Grenoble Alpes
    Grenoble, France
    Recruiting
  • Hôpital Européen Marseille
    Marseille, France
    Not yet recruiting
  • Centre Médical Les Jasmins
    Metz, France
    Not yet recruiting
  • Hôpital de la Pitié Salpêtrière - AP-HP
    Paris, France
    Not yet recruiting
  • Polyclinique Saint-Laurent - Hospitalité Saint-Thomas de Villeneuve
    Rennes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.